| Literature DB >> 26204946 |
Jinhua Wang1, Weijia Ding2, Ruimin Wang3, Yipeng Du4, Huanliang Liu5, Xuehua Kong6, Chunyuan Li7.
Abstract
Racemic new cyclohexenone and cyclopentenone derivatives, (±)-(4R*,5S*,6S*)-3-amino-4,5,6-trihydroxy-2-methoxy-5-methyl-2-cyclohexen-1-one (1) and (±)-(4S*,5S*)-2,4,5-trihydroxy-3-methoxy-4-methoxycarbonyl-5-methyl-2-cyclopenten-1-one (2), and two new xanthone derivatives 4-chloro-1,5-dihydroxy-3-hydroxymethyl-6-methoxycarbonyl-xanthen-9-one (3) and 2,8-dimethoxy-1,6-dimethoxycarbonyl-xanthen-9-one (4), along with one known compound, fischexanthone (5), were isolated from the culture of the mangrove endophytic fungus Alternaria sp. R6. The structures of these compounds were elucidated by analysis of their MS (Mass), one and two dimensional NMR (nuclear magnetic resonance) spectroscopic data. Compounds 1 and 2 exhibited potent ABTS [2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)] scavenging activities with EC50 values of 8.19 ± 0.15 and 16.09 ± 0.01 μM, respectively. In comparison to Triadimefon, compounds 2 and 3 exhibited inhibitory activities against Fusarium graminearum with minimal inhibitory concentration (MIC) values of 215.52 and 107.14 μM, respectively, and compound 3 exhibited antifungal activity against Calletotrichum musae with MIC value of 214.29 μM.Entities:
Keywords: Alternaria sp.; antimicrobial activity; antioxidant activity; cyclohexenone; cyclopentenone; secondary metabolites; xanthone
Mesh:
Substances:
Year: 2015 PMID: 26204946 PMCID: PMC4515629 DOI: 10.3390/md13074492
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–5.
1H and 13C NMR data of compounds 1 and 2.
| Position | 1 a | 2 a | ||
|---|---|---|---|---|
| δC, mult. | δH | δC, mult. | δH | |
| 1 | 185.62, C | - | 197.95, C | - |
| 2 | 126.93, C | - | 132.96, C | - |
| 3 | 156.36, C | - | 157.68, C | - |
| 4 | 71.55, CH | 4.22 (s) | 81.97, C | - |
| 5 | 77.97, C | - | 78.15, C | - |
| 6 | 76.99, CH | 3.72 (s) | - | - |
| 2-OCH3 | 58.13, CH3 | 3.46 (s) | - | - |
| 2-OH | - | - | - | 9.00 (s) |
| 3-NH2 | - | 6.30 (s), 6.83 (s) | - | - |
| 3-OCH3 | - | - | 58.55, CH3 | 3.99 (s) |
| 4-OH | - | 5.94 (s) | - | 6.10 (s) |
| 5-CH3 | 13.39, CH3 | 0.83 (s) | 22.16, CH3 | 1.16 (s) |
| 5-OH | - | 4.94 (s) | - | 5.63 (s) |
| 6-OH | - | 4.50 (s) | - | - |
| 4′ | - | - | 171.13, C | - |
| 4′-OCH3 | - | - | 52.06, CH3 | 3.59 (s) |
a Measured in (CD3)2SO at 600 MHz (1H) and 150 MHz (13C).
1H and 13C NMR data of compounds 3 and 4, J in Hz.
| Position | 3 a | 4 b | ||
|---|---|---|---|---|
| δC, mult. | δH ( | δC, mult. | δH ( | |
| 1 | 159.55, C | - | 120.71, C | - |
| 2 | 108.59, CH | 6.98 (s) | 152.78, C | - |
| 3 | 150.57, C | - | 119.49, CH | 7.52 (d, 9.6) |
| 4 | 107.95, C | - | 119.07, CH | 7.38 (d, 8.4) |
| 5 | 149.15, C | - | 111.29, CH | 7.72 (d, 1.2) |
| 6 | 117.63, C | - | 135.66, C | - |
| 7 | 126.08, CH | 7.49 (d, 9.0) | 105.52, CH | 7.41 (d, 1.2) |
| 8 | 120.74, CH | 7.68 (d, 9.0) | 160.89, C | - |
| 9 | 180.73, C | - | 175.06, C | - |
| 10 | 61.03, CH2 | 4.65 (d, 5.4) | 167.74, C | - |
| 11 | 167.09, C | - | 165.52, C | - |
| 1′ | 107.11, C | - | 121.40, C | - |
| 4′ | 150.78, C | - | 149.18, C | - |
| 5′ | 151.61, C | - | 157.43, C | - |
| 8′ | 117.57, C | - | 114.18, C | - |
| 1-OH | - | 12.20 (s) | - | - |
| 2-OCH3 | - | - | 56.96, CH3 | 3.92 (s) |
| 5-OH | - | 10.59 (s) | - | - |
| 8-OCH3 | - | - | 56.79, CH3 | 4.06 (s) |
| 10-OH | - | 5.71 (s) | - | - |
| 10-OCH3 | - | - | 53.03, CH3 | 4.09 (s) |
| 11-OCH3 | 52.78, CH3 | - | 52.83, CH3 | 4.00 (s) |
a Measured in (CD3)2SO at 600 MHz (1H) and 150 MHz (13C); b Measured in CDCl3 at 600 MHz (1H) and 150 MHz (13C).
Figure 2Key HMBC and NOESY correlations of compounds 1–4.
ABTS radical scavenging activities of compounds 1–4 (EC50, μM) a.
| Compounds | 1 | 2 | 3 | 4 | Ascorbic Acid b |
|---|---|---|---|---|---|
| EC50 | 8.19 ± 0.15 | 16.09 ± 0.01 | >500.00 | >500.00 | 17.14 ± 0.11 |
a EC50 values are taken as means ± standard deviation from three independent experiment; b Used as a positive control.
Antimicrobial activities of isolated compounds (minimal inhibitory concentration (MIC), μM).
| 738.92 | >1970.44 | 1970.44 | 1970.44 | |
| 215.52 | 862.07 | 1724.14 | 1724.14 | |
| 107.14 | 214.29 | NT | NT | |
| 474.68 | 474.68 | >1265.82 | >1265.82 | |
| Cefradine a | NT | NT | 143.10 | 17.89 |
| Kanamycin a | NT | NT | 1.54 | 1.54 |
| Triadimefon a | 510.64 | 340.43 | NT | NT |
a Used as a positive control. “NT” means “not detected”.